KNOW HYPOPARA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

KNOW HYPOPARA Trademark

Serial Number: 98041718 • Registration: 8055222

KNOW HYPOPARA is a trademark filed by Ascendis Pharma Endocrinology Division A/S on June 14, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma Endocrinology Division A/S (14 trademarks)

Hellerup 2900 , DK

Entity Type: 99

Trademark Details

Filing Date

June 14, 2023

Registration Date

December 9, 2025

Published for Opposition

December 10, 2024

Goods & Services

Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, and health care; Publication of non-downloadable electronic publications in the nature of advisory board reports, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Educational services, namely, conducting educational programs for patients and healthcare providers related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

Providing and sharing of medical information and advice relating to growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, medical screening, medicine, health and pharmaceutical products; Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Nov 14, 2025 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 10, 2025 AITU
NOTICE OF ALLOWANCE CANCELLED
Jul 2, 2025 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 2, 2025 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 6, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 21, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 21, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 21, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2024 CRFA
ASSIGNED TO LIE
Sep 26, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 30, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 29, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
May 29, 2024 GNSL
SUSPENSION LETTER WRITTEN
May 29, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 19, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2023 NWOS
NEW APPLICATION ENTERED
Jun 17, 2023 NWAP